Skip to main content
. 2017 Dec 9;9(1):982–994. doi: 10.18632/oncotarget.23140

Table 1. Clinical characteristics of included patients (n=140).

Clinical characteristics All patients (n=140) No. (%)
Age (Median) [years] 65.7
Follow up (Median) [months] 82.7
Histology
 Endometrioid 102 (72.9)
 Serous 11 (7.9)
 Mucinous 6 (4.3)
 Mixed cell 19 (13.6)
 Undifferentiated 2 (1.4)
FIGO stage
 I 104 (74.3)
 II 9 (6.4)
 III 23 (16.4)
 IV 4 (2.9)
WHO grading
 1 67 (47.9)
 2 46 (32.9)
 3 27 (19.3)
Lymph node involvement
 No 119 (85.0)
 Yes 16 (11.4)
 Unknown 5 (3.6)
Metastasis at first dignosis
 No 117 (83.6)
 Yes 11 (7.9)
 Unknown 12 (8.6)
Recurrence
 No 110 (78.6)
 Yes 18 (12.9)
 Unknown 12 (8.6)

FIGO: International Federation of Gynecology and Obstetrics; WHO: World Health Organization.